PeptideCompareHome / Peptide Database / Survodutide
GLP-1 · GLUCAGON — WEIGHT / MASH
Survodutide
Survodutide (BI 456906) is a dual GLP-1 receptor and glucagon receptor agonist developed by Boehringer Ingelheim / Zealand Pharma, studied for obesity and MASH (metabolic-associated steatohepatitis).
Available strengths
10mg
1 of 1 rows in stock
How to use it: compare suppliers below side by side on price and whether a COA is on file — those two checks are the fastest way to spot a good deal. All COAs can be verified directly on each supplier's own website.
Prices manually checked and updated monthly — source: publicly available supplier data. No affiliate links, no paid placement.
Survodutide
Mechanism, evidence level, EU status and COA guidance per compound. No dosages, no protocols — that belongs with a doctor.